Search for: "IN RE KUBIN" Results 41 - 60 of 78
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2012, 7:10 pm by Lawrence B. Ebert
As in In re Kubin, this claim language does not impose any additional requirement because the ’805 patent itself defines mast cell stabilization as a property that is neces- sarily present at those concentrations. [read post]
4 Feb 2008, 3:16 am
The CAFC upheld the Board under the 'broadest reasonable interpretation rule'"A link to precedential and informative decisions from the Board of Appeals: [www.uspto.gov] "This link provides three post KSR decisions on obviousness - Catan, Kubin, and Smith. [read post]
18 Jul 2011, 8:21 am by Stefanie Levine
Alphapharm, In re Kubin While theoretically, KSR lowered the bar to obviousness by allowing consideration of obvious to try, obviousness-based patent attacks have met with little success Claims and patents covering chemical compounds of a particular structure remain strong Consider a narrow claim to particular compounds of interest Evaluate your arsenal of secondary considerations to understand the strength/weakness of your claim Obviousness-Type Double Patenting – a later… [read post]
18 Jul 2011, 8:21 am by Stefanie Levine
Alphapharm, In re Kubin While theoretically, KSR lowered the bar to obviousness by allowing consideration of obvious to try, obviousness-based patent attacks have met with little success Claims and patents covering chemical compounds of a particular structure remain strong Consider a narrow claim to particular compounds of interest Evaluate your arsenal of secondary considerations to understand the strength/weakness of your claim Obviousness-Type Double Patenting – a later… [read post]
10 Nov 2009, 4:28 pm
" We have posted about the landmark Bilski case from the very beginning and our line of reasoning - prior to the court decisions - anticipated what the courts decided: In re Kubin : Hitting the NAIL on the Head : Sequencing Poor Federal Circuit Court Decisions out of the Biotechnology Patent Genome via KSR and/or Bilski Reasoning In re Bilski : Patentable Subject Matter : Federal Circuit Overturns Pure Business Method Patents : Requires Machine Process / Physical… [read post]
6 Aug 2009, 11:24 pm
Cir. 2009); In re Kubin, 561 F.3d 1351, 1359, (Fed. [read post]
13 May 2009, 11:44 pm
" In re Kubin, __ F.3d __, No. 2008-1184, slip op. at 14 (Fed. [read post]
9 Oct 2014, 11:49 am by Jim Walker
I anticipate that if there are any crew members from these countries, they will not be be re-hired when they return home on vacation. [read post]
17 Feb 2011, 11:58 am by Stefanie Levine
. -2010 – Examination Guidelines Update: Developments in the Obviousness Inquiry after KSR Analysis must be made explicit Applies to all arts equally (In re Kubin) Includes examples kof both obvious and nonobvious claims from Federal Circuit cases (combining prior art elements, substituting one known element for another, “obvious to try”, consideration of evidence. [read post]
9 Dec 2011, 2:44 am by Lawrence B. Ebert
(Re)formulation of the technical problem in the sense referred to here iscarried out essentially for the purpose of assessing whether or not theinvention is or is not obvious. [read post]
27 Sep 2008, 12:08 am
You can separately subscribe to the Pharma & Biotech edition of the Global week in Review by subscribing by email, or selecting ‘all posts’ or Pharma, Biotech & Chem' for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Canada/Africa: Apotex ships patented AIDS drugs to Rwanda under Canada's Access to Medicines Regime (CAMR) (Managing Intellectual Property) (GenericsWeb) Consolidation in the generic… [read post]
12 Mar 2016, 7:44 am by Rebecca Tushnet
They’re uniquely positioned to provide standardization guidance, especially since they’re dealing with patents that will be very valuable if the standard is accepted. [read post]
19 May 2011, 9:12 pm
" In re Kubin, 561 F.3d 1351, 1360 (Fed. [read post]
7 Oct 2013, 11:06 am by Lawrence B. Ebert
An analysis of obviousness must be based on several factual inquiries: (1) the scope and content of the prior art; (2) the differ- ences between the prior art and the claims at is- sue; (3) the level of ordinary skill in the art at the time the invention was made; and (4) objective ev- idence of nonobviousness, if any.In re Kubin, 561 F.3d 1351, 1355 (Fed. [read post]
15 Feb 2010, 9:15 am by Lawrence B. Ebert
" See In re Gal, 980 F.2d 717, 25 USPQ2d 1076 (Fed. [read post]
3 Dec 2009, 8:04 pm
" In re Kubin, 561 F.3d 1351, 1355 (Fed. [read post]